TrialNature communications2024

Multipeptide vaccines for melanoma in the adjuvant setting: long-term survival outcomes and post-hoc analysis of a randomized phase II trial.

Emily K Ninmer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.